Drugs Made In America Acquisition DMAA
Drugs Made In America Acquisition: annual report for the year ended Dec 31, 2024
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0001213900-25-026240
- Document
- 10-K
- Exhibit 4.5
- Description of the company's securities
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 6770 and related industry codes: the same peer list as the financial tables.
- Archimedes Tech SPAC Partners II ATII public float $235M, Jun 30, 2025
- Fifth Era Acquisition Corp I FERA public float $236M, Jun 30, 2025
- Sizzle Acquisition Corp. II SZZL public float $233M, Jun 30, 2025
- GSR IV Acquisition GSRF public float $236M, Jun 30, 2025
- Jena Acquisition Corp II JENA public float $236M, Jun 30, 2025
